Spectral AI (MDAI) Stock Price, News & Analysis

Company Overview

Spectral AI, Inc. is a medical technology company that develops artificial intelligence and multispectral imaging solutions for wound-care diagnostics. Its technology is designed to help clinicians assess wounds and predict healing outcomes more quickly and objectively than visual examination alone.

The company’s principal product is the DeepView System, a noninvasive imaging and decision-support platform intended to evaluate the healing potential of burns and other wounds, including diabetic foot ulcers. DeepView analyzes tissue characteristics using optical imaging and artificial intelligence to support treatment decisions, such as determining whether burned tissue is likely to heal naturally or may require surgical intervention.

Founded in 2009 and headquartered in Dallas, Texas, Spectral AI has focused on developing and clinically evaluating its technology for use in hospital and wound-care settings. The DeepView System has received U.S. Food and Drug Administration Breakthrough Device designation for certain applications. Spectral AI became a publicly traded company on Nasdaq in 2023.

Key Stats

• Today's Range: $1.61 to $1.68
• 50-Day Range: $1.55 to $1.75
• 52-Week Range: $1.18 to $2.97
• Volume: 86,787 shs
• Average Volume: 477,290 shs
• Market Capitalization: $52.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Moderate Buy

Spectral AI Stock Analysis - MarketRank™

Spectral AI scored higher than 36% of companies evaluated by MarketBeat, and ranked 683rd out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Spectral AI has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Spectral AI has a consensus price target of $4.00, representing about 145.4% upside from its current price of $1.63.

Amount of Analyst Coverage

Spectral AI has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Spectral AI are expected to grow in the coming year, from ($0.50) to ($0.36) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Spectral AI is -4.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Spectral AI is -4.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.90% of the float of Spectral AI has been sold short.

Short Interest Ratio / Days to Cover

Spectral AI has a short interest ratio ("days to cover") of 21.88, which indicates bearish sentiment.

Change versus previous month

Short interest in Spectral AI has recently decreased by 1.76%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Spectral AI does not currently pay a dividend.

Dividend Growth

Spectral AI does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 4 news articles for Spectral AI this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for MDAI on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Spectral AI insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.70% of the stock of Spectral AI is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

67.08% of the stock of Spectral AI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/11/2026
• Today: 10/07/2026
• Next Earnings (Estimated): 11/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:MDAI
• CIK: 1833498
• Web: www.spectral-ai.com
• Phone: 212-492-3000
• Fax: N/A
• Employees: 65
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Spectral AI: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +143.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.35)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.57 million
• Net Margins: -69.27%
• Pretax Margin: -65.78%
• Return on Equity: N/A
• Return on Assets: -78.56%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.90
• Quick Ratio: 0.85

Sales & Book Value

• Annual Sales: $19.65 million
• Price / Sales: 2.69
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.19) per share
• Price / Book: -8.63

Miscellaneous

• Outstanding Shares: 32,190,000
• Free Float: 27,776,000
• Market Cap: $52.79 million
• Optionable: Not Optionable
• Beta: 1.21